Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announces that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a privately held developer of breast cancer surgery technologies, for approximately $310 million, subject to working capital and other customary closing adjustments. Endomag, which is based in Cambridge, United Kingdom, develops and sells breast surgery localization and lymphatic tracing technologies. Its products include the Magseed® marker for magnetic tissue localization before surgery, the Magtrace® lymphatic tracing injectable for breast cancer staging and the Sentimag® platform, which supports both localization and lymphatic tracing.

Read the full article: Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company //

Source: https://www.businesswire.com/news/home/20240429961559/en/Hologic-to-Acquire-Endomagnetics-Ltd-a-Breast-Surgical-Guidance-Company

Leave a Comment

Your email address will not be published.

Scroll to Top